NASDAQ Composite ended the session with ImmunoGen rising 2.37% to $7.76 on Thursday, after two sequential sessions in a row of gains. NASDAQ Composite dropped 0.94% to $13,818.41, following last session’s upward trend on what was a somewhat negative trend trading session today.
ImmunoGen today’s close was $7.76, 40.21% below its 52-week high of $10.88.
ImmunoGen’s sales growth is 33.4% for the present quarter and 34.9% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 11.8% and a negative 28.6%, respectively.
Year-on-year quarterly revenue growth grew by 91.2%, now sitting on 132.3M for the twelve trailing months.
ImmunoGen’s last day, last week, and last month’s current volatility was 3.55%, 2.45%, and 2.80%, respectively.
ImmunoGen‘s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 6.29% (day), 4.70% (last week), and 4.96% (last month), respectively.
ImmunoGen’s Stock Yearly Top and Bottom Value
ImmunoGen’s stock is valued at $7.76 at 17:25 EST, way under its 52-week high of $10.88 and way higher than its 52-week low of $3.34.
ImmunoGen’s Moving Average
ImmunoGen’s value is way below its 50-day moving average of $8.73 and way above its 200-day moving average of $6.76.
More news about ImmunoGen.